Yttrium-90 radioembolization using TheraSphere® in the management of primary and secondary liver tumors

A. Riaz, R. J. Lewandowski, L. Kulik, R. Salem*

*Corresponding author for this work

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Locoregional therapies, such as transarterial chemoembolization, radioembolization and thermal ablation (e.g., radiofrequency ablation) are establishing their roles in the management of liver malignancies. With yYttrium-90 radioembolization therapy (90Y) radionuclide labeled microspheres are injected into the tumor feeding artery. This allows the delivery of a high radioactive dose to the tumor with minimal toxicity to normal tissues. 90Y has demonstrated to be safe and effective in the management of liver tumors. Authors present a review of the literature available for the use of TheraSphere® for radioembolization in the management of liver tumors.

Original languageEnglish (US)
Pages (from-to)311-316
Number of pages6
JournalQuarterly Journal of Nuclear Medicine and Molecular Imaging
Volume53
Issue number3
StatePublished - Jun 1 2009

Fingerprint

Yttrium
Liver
Neoplasms
Microspheres
Radioisotopes
Arteries
Hot Temperature
Therapeutics

Keywords

  • Carcinoma, hepatocellular
  • Liver neoplasms
  • Operative
  • Surgical procedures

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

@article{8cfb52e464504f5bbffc9c22ceadad4b,
title = "Yttrium-90 radioembolization using TheraSphere{\circledR} in the management of primary and secondary liver tumors",
abstract = "Locoregional therapies, such as transarterial chemoembolization, radioembolization and thermal ablation (e.g., radiofrequency ablation) are establishing their roles in the management of liver malignancies. With yYttrium-90 radioembolization therapy (90Y) radionuclide labeled microspheres are injected into the tumor feeding artery. This allows the delivery of a high radioactive dose to the tumor with minimal toxicity to normal tissues. 90Y has demonstrated to be safe and effective in the management of liver tumors. Authors present a review of the literature available for the use of TheraSphere{\circledR} for radioembolization in the management of liver tumors.",
keywords = "Carcinoma, hepatocellular, Liver neoplasms, Operative, Surgical procedures",
author = "A. Riaz and Lewandowski, {R. J.} and L. Kulik and R. Salem",
year = "2009",
month = "6",
day = "1",
language = "English (US)",
volume = "53",
pages = "311--316",
journal = "Quarterly Journal of Nuclear Medicine and Molecular Imaging",
issn = "1824-4785",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Yttrium-90 radioembolization using TheraSphere® in the management of primary and secondary liver tumors

AU - Riaz, A.

AU - Lewandowski, R. J.

AU - Kulik, L.

AU - Salem, R.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Locoregional therapies, such as transarterial chemoembolization, radioembolization and thermal ablation (e.g., radiofrequency ablation) are establishing their roles in the management of liver malignancies. With yYttrium-90 radioembolization therapy (90Y) radionuclide labeled microspheres are injected into the tumor feeding artery. This allows the delivery of a high radioactive dose to the tumor with minimal toxicity to normal tissues. 90Y has demonstrated to be safe and effective in the management of liver tumors. Authors present a review of the literature available for the use of TheraSphere® for radioembolization in the management of liver tumors.

AB - Locoregional therapies, such as transarterial chemoembolization, radioembolization and thermal ablation (e.g., radiofrequency ablation) are establishing their roles in the management of liver malignancies. With yYttrium-90 radioembolization therapy (90Y) radionuclide labeled microspheres are injected into the tumor feeding artery. This allows the delivery of a high radioactive dose to the tumor with minimal toxicity to normal tissues. 90Y has demonstrated to be safe and effective in the management of liver tumors. Authors present a review of the literature available for the use of TheraSphere® for radioembolization in the management of liver tumors.

KW - Carcinoma, hepatocellular

KW - Liver neoplasms

KW - Operative

KW - Surgical procedures

UR - http://www.scopus.com/inward/record.url?scp=70349576355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349576355&partnerID=8YFLogxK

M3 - Review article

C2 - 19521310

AN - SCOPUS:70349576355

VL - 53

SP - 311

EP - 316

JO - Quarterly Journal of Nuclear Medicine and Molecular Imaging

JF - Quarterly Journal of Nuclear Medicine and Molecular Imaging

SN - 1824-4785

IS - 3

ER -